{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:21:40Z","timestamp":1789726900622,"version":"4.0.1"},"reference-count":42,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":289,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"name":"NIH\/NHLBI","award":["T32HL007024"],"award-info":[{"award-number":["T32HL007024"]}]},{"name":"NIH\/NIDDK","award":["R01DK089174"],"award-info":[{"award-number":["R01DK089174"]}]},{"name":"NIH\/NIDDK","award":["K24DK106414"],"award-info":[{"award-number":["K24DK106414"]}]},{"name":"NIH\/NIDDK","award":["HHSN268201100005C"],"award-info":[{"award-number":["HHSN268201100005C"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>We compared levels and associations of traditional (fasting glucose, HbA1c) and nontraditional (fructosamine, glycated albumin, and 1,5-anhydroglucitol [1,5-AG]) biomarkers of hyperglycemia with incident cardiovascular disease (CVD), incident end-stage renal disease (ESRD), and prevalent retinopathy in black and white adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We included 10,373 participants without (8,096 white, 2,277 black) and 727 with diagnosed diabetes (425 white, 302 black) from the Atherosclerosis Risk in Communities (ARIC) Study. We used Cox proportional hazards models to compare hazards ratios of CVD and ESRD among blacks and whites from baseline (1990\u20131992) through 2012. We compared the odds ratios (from logistic regression) of retinopathy among blacks and whites. We tested for the interaction of each biomarker with race.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Median values of biomarkers were higher among blacks versus whites (all P &amp;lt; 0.001). Relative risks for each biomarker with incident CVD and ESRD, and odds ratios for each biomarker with prevalent retinopathy, were similar by race (all P values for interaction by race &amp;gt;0.10).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The prognostic value of HbA1c, fructosamine, glycated albumin, and 1,5-AG with incident CVD, incident ESRD, and prevalent retinopathy were similar by race. Our results support similar interpretation of HbA1c and nontraditional biomarkers of hyperglycemia among black and whites with respect to long-term complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc15-1360","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T20:07:44Z","timestamp":1452197264000},"page":"589-595","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":23,"title":["Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia"],"prefix":"10.2337","volume":"39","author":[{"given":"Christina M.","family":"Parrinello","sequence":"first","affiliation":[{"name":"Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Richey","family":"Sharrett","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisa M.","family":"Maruthur","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD"},{"name":"Division of General Internal Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Bergenstal","sequence":"additional","affiliation":[{"name":"International Diabetes Center, Park Nicollet Health Services, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD"},{"name":"Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD"},{"name":"Division of General Internal Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD"},{"name":"Division of General Internal Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2015,12,17]]},"reference":[{"key":"2022031220275544100_B1","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dc15-S005","article-title":"Classification and diagnosis of diabetes","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11892-014-0548-3","article-title":"Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management","volume":"14","author":"Parrinello","year":"2014","journal-title":"Curr Diab Rep"},{"key":"2022031220275544100_B3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","article-title":"Tests of glycemia in diabetes","volume":"27","author":"Goldstein","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/dc10-1546","article-title":"A1C versus glucose testing: a comparison","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B5","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/clinchem\/33.12.2153","article-title":"Fructosamine: structure, analysis, and clinical usefulness","volume":"33","author":"Armbruster","year":"1987","journal-title":"Clin Chem"},{"key":"2022031220275544100_B6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/152091503765691839","article-title":"Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker","volume":"5","author":"Buse","year":"2003","journal-title":"Diabetes Technol Ther"},{"key":"2022031220275544100_B7","first-page":"9","article-title":"1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions","volume-title":"Expert Rev Mol Diagn","author":"Dungan","year":"2008"},{"key":"2022031220275544100_B8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12020-012-9760-6","article-title":"1,5-Anhydroglucitol in diabetes mellitus","volume":"43","author":"Kim","year":"2013","journal-title":"Endocrine"},{"key":"2022031220275544100_B9","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1016\/0168-8227(94)90259-3","article-title":"Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control","volume":"24","author":"Yamanouchi","year":"1994","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031220275544100_B10","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(96)90672-8","article-title":"Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control","volume":"347","author":"Yamanouchi","year":"1996","journal-title":"Lancet"},{"key":"2022031220275544100_B11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S2213-8587(13)70199-2","article-title":"Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"2","author":"Selvin","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031220275544100_B12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1373\/clinchem.2014.229427","article-title":"Association of 1,5-anhydroglucitol with diabetes and microvascular conditions","volume":"60","author":"Selvin","year":"2014","journal-title":"Clin Chem"},{"key":"2022031220275544100_B13","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/dc10-1945","article-title":"Nontraditional markers of glycemia: associations with microvascular conditions","volume":"34","author":"Selvin","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2337\/db10-1198","article-title":"Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes","volume":"60","author":"Selvin","year":"2011","journal-title":"Diabetes"},{"key":"2022031220275544100_B15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N Engl J Med"},{"key":"2022031220275544100_B16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2011.02.033","article-title":"Serum 1,5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study","volume":"216","author":"Watanabe","year":"2011","journal-title":"Atherosclerosis"},{"key":"2022031220275544100_B17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.115.015415","article-title":"Fructosamine and glycated albumin and the risk of cardiovascular outcomes and death","volume":"132","author":"Selvin","year":"2015","journal-title":"Circulation"},{"key":"2022031220275544100_B18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"key":"2022031220275544100_B19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1753-0407.2010.00070.x","article-title":"Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study","volume":"2","author":"Selvin","year":"2010","journal-title":"J Diabetes"},{"key":"2022031220275544100_B20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1373\/clinchem.2010.150250","article-title":"Determining stability of stored samples retrospectively: the validation of glycated albumin","volume":"57","author":"Nathan","year":"2011","journal-title":"Clin Chem"},{"key":"2022031220275544100_B21","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1373\/clinchem.2012.188367","article-title":"Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose","volume":"58","author":"Juraschek","year":"2012","journal-title":"Clin Chem"},{"key":"2022031220275544100_B22","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2337\/dc12-1896","article-title":"Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients","volume":"36","author":"Shafi","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B23","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc12-0787","article-title":"Alternative markers of hyperglycemia and risk of diabetes","volume":"35","author":"Juraschek","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/ajcn\/36.5.936","article-title":"A short questionnaire for the measurement of habitual physical activity in epidemiological studies","volume":"36","author":"Baecke","year":"1982","journal-title":"Am J Clin Nutr"},{"key":"2022031220275544100_B25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022031220275544100_B26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0895-4356(95)00041-0","article-title":"Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years\u2019 experience","volume":"49","author":"White","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"2022031220275544100_B27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.30.4.736","article-title":"Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort","volume":"30","author":"Rosamond","year":"1999","journal-title":"Stroke"},{"key":"2022031220275544100_B28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjcard.2007.11.061","article-title":"Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study)","volume":"101","author":"Loehr","year":"2008","journal-title":"Am J Cardiol"},{"key":"2022031220275544100_B29","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0161-6420(99)90525-0","article-title":"Methods for evaluation of retinal microvascular abnormalities associated with hypertension\/sclerosis in the Atherosclerosis Risk in Communities Study","volume":"106","author":"Hubbard","year":"1999","journal-title":"Ophthalmology"},{"key":"2022031220275544100_B30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9394(01)01315-0","article-title":"Reliability of retinal photography in the assessment of retinal microvascular characteristics: the Atherosclerosis Risk in Communities Study","volume":"133","author":"Couper","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"2022031220275544100_B31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0161-6420(02)01074-6","article-title":"The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the Atherosclerosis Risk in Communities study","volume":"109","author":"Klein","year":"2002","journal-title":"Ophthalmology"},{"key":"2022031220275544100_B32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc12-0404","article-title":"No ethnic differences in the association of glycated hemoglobin with retinopathy: the national health and nutrition examination survey 2005-2008","volume":"36","author":"Bower","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B33","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2337\/dc12-2715","article-title":"No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes","volume":"36","author":"Selvin","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/0003-4819-157-3-201208070-00004","article-title":"Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study","volume":"157","author":"Tsugawa","year":"2012","journal-title":"Ann Intern Med"},{"key":"2022031220275544100_B35","first-page":"689","article-title":"Diagnosis of diabetes mellitus using HbA1c in Asians: relationship between HbA1c and retinopathy in a multiethnic Asian population","volume-title":"J Clin Endocrinol Metab","author":"Sabanayagam","year":"2015"},{"key":"2022031220275544100_B36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","author":"International Expert Committee","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031220275544100_B37","first-page":"c1; author reply c2","article-title":"A conundrum addressed: the prognostic value of HbA1c","volume-title":"Nat Rev Endocrinol","author":"Selvin","year":"2011"},{"key":"2022031220275544100_B38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-154-5-201103010-00004","article-title":"Racial differences in glycemic markers: a cross-sectional analysis of community-based data","volume":"154","author":"Selvin","year":"2011","journal-title":"Ann Intern Med"},{"key":"2022031220275544100_B39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2337\/diaclin.30.3.130","article-title":"The disparate impact of diabetes on racial\/ethnic minority populations","volume":"30","author":"Chow","year":"2012","journal-title":"Clin Diabetes"},{"key":"2022031220275544100_B40","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.283.17.2253","article-title":"Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study","volume":"283","author":"Brancati","year":"2000","journal-title":"JAMA"},{"key":"2022031220275544100_B41","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1464-5491.2012.03613.x","article-title":"Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes","volume":"29","author":"Kim","year":"2012","journal-title":"Diabet Med"},{"key":"2022031220275544100_B42"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc15-1360","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/4\/589\/625793\/dc151360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/4\/589\/625793\/dc151360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:26:14Z","timestamp":1647123974000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/39\/4\/589\/29104\/Racial-Differences-in-and-Prognostic-Value-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,17]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,12,17]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc15-1360","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,17]]}}}